Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implementation of cell‐free <scp>DNA</scp>‐based aneuploidy screening: perspectives from a national audit

17 Oct 2014

Abstract excerpt

In late 2011, a prenatal screening test for fetal chromosomal abnormalities using cell-free DNA in maternal plasma was introduced commercially in the USA. This next-generation sequencing-based method, commonly referred to as non-invasive prenatal testing (NIPT), represented the most accurate form of screening for trisomy 21 to date1. While the NIPT market expanded rapidly in the USA, its clinical implementation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25323392
DOI: 10.1002/uog.14699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implementation of cell‐free <scp>DNA</scp>‐based aneuploidy screening: perspectives from a national auditPMID 25323392Read ↗

National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell‐free DNA aneuploidy screeningSemantic proximity Read ↗

Delivering an accredited non‐invasive prenatal diagnosis service for monogenic disorders and recommendations for best practiceSemantic proximity Read ↗

Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US contextSemantic proximity Read ↗

A decade of non‐invasive prenatal screening in Australia: National impact on prenatal screening and diagnostic testingSemantic proximity Read ↗

Cell-Free DNA ScreeningSemantic proximity Read ↗

Performance of non‐invasive prenatal testing when fetal cell‐free <scp>DNA</scp> is absentSemantic proximity Read ↗

Implementation of maternal blood cell‐free <scp>DNA</scp> testing in early screening for aneuploidiesSemantic proximity Read ↗

Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samplesSemantic proximity Read ↗

<scp>UK NHS</scp> pilot study on cell‐free <scp>DNA</scp> testing in screening for fetal trisomies: factors affecting uptakeSemantic proximity Read ↗

Non-Invasive Prenatal Diagnosis Using Cell-Free Fetal DNA Technology: Applications and ImplicationsSemantic proximity Read ↗

State‐wide utilization and performance of traditional and cell‐free DNA‐based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) studySemantic proximity Read ↗

Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.